Literature DB >> 15251725

Acromegaly and non-Hodgkin's lymphoma.

R H Alves1, M Vaisman, R R Brasil, M R Gadelha.   

Abstract

OBJECTIVE: To present the fourth case report of development of a non-Hodgkin's lymphoma in a patient with active acromegaly.
METHODS: We describe the clinical, laboratory, and imaging findings in a patient with untreated acromegaly in whom a large cell non-Hodgkin's lymphoma developed.
RESULTS: Acromegaly is associated with several comorbid conditions. Among these is a higher incidence of several types of visceral malignant lesions, especially carcinoma of the colon. Growth hormone stimulates the hepatic production of somatomedins, such as insulin-like growth factors, which are known promoters of human growth and have also been implicated in tumorigenesis. In recent years, several cases of lymphoproliferative diseases have also been noted in patients with acromegaly. These conditions include multiple myeloma, lymphoma, and leukemia; three previous cases of non-Hodgkin's lymphoma have been described. In our patient, a 57-year-old man with acromegaly, magnetic resonance imaging of the pituitary gland disclosed a large intrasellar mass. Large cell non-Hodgkin's lymphoma was diagnosed. Six months of chemotherapy yielded complete remission.
CONCLUSION: An additional case of non-Hodgkin's lymphoma in a patient with acromegaly supports the accumulating evidence of an increased risk for development of cancer in such patients.

Entities:  

Year:  1998        PMID: 15251725     DOI: 10.4158/EP.4.5.279

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  4 in total

1.  Insulin-like growth factor-1 is essential to the increased mortality caused by excess growth hormone: a case of thyroid cancer and non-Hodgkin's lymphoma in a patient with pituitary acromegaly.

Authors:  A Taslipinar; E Bolu; L Kebapcilar; M Sahin; G Uckaya; M Kutlu
Journal:  Med Oncol       Date:  2008-07-29       Impact factor: 3.064

Review 2.  Acromegaly: re-thinking the cancer risk.

Authors:  Siobhan Loeper; Shereen Ezzat
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

3.  Hematologic neoplasias and acromegaly.

Authors:  Flavia Regina P Barbosa; Leonardo Vieira Neto; Giovanna Aparecida B Lima; Luiz Eduardo Wildemberg; Rodrigo Portugal; Monica R Gadelha
Journal:  Pituitary       Date:  2011-12       Impact factor: 4.107

4.  The coexistence of an intrasellar adenoma, lymphocytic hypophysitis, and primary pituitary lymphoma in a patient with acromegaly.

Authors:  Jose Hernan Martinez; Mariel Davila Martinez; Marcos Mercado de Gorgola; Luis F Montalvo; Jaime E Tome
Journal:  Case Rep Endocrinol       Date:  2011-10-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.